|
|
Vaccine Detail
|
Ad41.MERS-S protein |
| Vaccine Information |
- Vaccine Name: Ad41.MERS-S protein
- Target Pathogen: MERS-CoV
- Target Disease: Middle East Respiratory Syndrome (MERS)
- Type: Recombinant vector vaccine
- Status: Licensed
- Host Species for Licensed Use: None
- Host Species as Laboratory Animal Model: mouse
- Antigen: S protein(Guo et al., 2015)
- Immunization Route: Intramuscular injection (i.m.)
- Description: Adenovirus type 41 used as vector for MERS-CoV S protein (Guo et al., 2015)
|
| Host Response |
|
|
| References |
Guo et al., 2015: Guo X, Deng Y, Chen H, Lan J, Wang W, Zou X, Hung T, Lu Z, Tan W. Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus. Immunology. 2015; 145(4); 476-484. [PubMed: 25762305].
|
|
